COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 3037: Articles 30361-30370  | Next

LY6E impairs coronavirus fusion and confers immune control of viral disease
Pfaender, S., Mar, K. B., Michailidis, E., Kratzel, A., Hirt, D., V'kovski, P., Fan, W., Ebert, N., Stalder, H., Kleine-Weber, H., Hoffmann, M., Hoffmann, H. H., Saeed, M., Dijkman, R., Steinmann, E., Wight-Carter, M., Hanners, N. W., Pohlmann, S., Gallagher, T., Todt, D., Zimmer, G., Rice, C. M., Schoggins, J. W., Thiel, V.
10.1101/2020.03.05.979260 — Posted: 2020-03-07 Discussion: Onsite
Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis Mechanisms of SARS-Related Coronaviruses
Tan, Y., Schneider, T., Leong, M., Aravind, L., Zhang, D.
10.1101/2020.03.04.977736 — Posted: 2020-03-07
Cryo-electron microscopy structure of the SADS-CoV spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins
Ouyang, S.
10.1101/2020.03.04.976258 — Posted: 2020-03-07 Discussion: Offsite
In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism
Othman, H., Bouslama, Z., Brandenburg, J.-T., da Rocha, J., Hamdi, Y., Ghedira, K., Abid, N.-S., Hazelhurst, S.
10.1101/2020.03.04.976027 — Posted: 2020-03-07
Direct RNA sequencing and early evolution of SARS-CoV-2
Taiaroa, G., Rawlinson, D., Featherstone, L., Pitt, M., Caly, L., Druce, J., Purcell, D., Harty, L., Tran, T., Roberts, J., Catton, M., Williamson, D., Coin, L., Duchene, S.
10.1101/2020.03.05.976167 — Posted: 2020-03-07 Discussion: Offsite
Nanopore target sequencing for accurate and comprehensive detection of SARS-CoV-2 and other respiratory viruses
Wang, M., Fu, A., Hu, B., Tong, Y., Liu, R., Gu, J., Liu, J., Jiang, W., Shen, G., Zhao, W., Men, D., Yu, L., Deng, Z., Li, Y., Liu, T.
10.1101/2020.03.04.20029538 — Posted: 2020-03-06 Discussion: Onsite
68 Consecutive patients assessed for COVID-19 infection; experience from a UK regional infectious disease unit
Easom, N., Moss, P., Barlow, G., Samson, A., Taynton, T., Adams, K., Ivan, M., Burns, P., Gajee, K., Eastick, K., Lillie, P.
10.1101/2020.02.29.20029462 — Posted: 2020-03-06
Evaluation of the incidence of COVID-19 and of the efficacy of contention measures in Spain: a data-driven approach.
Aleta, A., Moreno, Y.
10.1101/2020.03.01.20029801 — Posted: 2020-03-06
The effect of human mobility and control measures on the COVID-19 epidemic in China
Kraemer, M. U. G., Yang, C.-H., Gutierrez, B., Wu, C.-H., Klein, B., Pigott, D. M., open COVID-19 data working group, , du Plessis, L., Faria, N. R., Li, R., Hanage, W. P., Brownstein, J. S., Layan, M., Vespignani, A., Tian, H., Dye, C., Cauchemez, S., Pybus, O., Scarpino, S. V.
10.1101/2020.03.02.20026708 — Posted: 2020-03-06
Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province
Wan, H., Cui, J.-a., Yang, G.-J.
10.1101/2020.03.01.20029629 — Posted: 2020-03-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).